Effect of insulin on the hepatic production of insulin-like growth factor-binding protein-1 (IGFBP-1), IGFBP-3, and IGF-I in insulin-dependent diabetes

作者: K Brismar , E Fernqvist-Forbes , J Wahren , K Hall

DOI: 10.1210/JCEM.79.3.7521354

关键词: Insulin-like growth factor-binding proteinInsulinSomatomedinInternal medicineBasal (medicine)SplanchnicDiabetes mellitusSplanchnic CirculationInsulin oscillationChemistryEndocrinology

摘要: Insulin-like growth factors (IGFs) circulate attached to binding proteins (IGFBPs). Only the unbound form of IGF is suggested be biological active. The main source circulating IGF-I and IGFBP-1 considered liver, but that IGFBP-3 not known. are GH dependent, whereas insulin regulated. aim present study was examine effect on hepatic secretion IGFBP-1, IGFBP-3, IGF-I. Seven insulin-dependent diabetic patients in whom withheld for 12 h were studied overnight fasted state. Blood sampled simultaneously from vein, a peripheral an artery before during infusion 3 h. basal levels vein several-fold elevated (249 +/- 44 micrograms/L) compared those healthy subjects (37 2 micrograms/L). Fasting concentrations inversely correlated (r = -0.918; P < 0.001). mean concentration (175 17 micrograms/L; -1.62 0.38 SD score) decreased with age-matched subjects. (4.50 0.33 mg/L) within normal range. There significant correlation between fasting 0.928; Basal splanchnic production 18 7 micrograms/min, no net exchanges or observed across area. Insulin inhibited 120 min glucose output 20 min. Serum IGF-I, increased significantly infusion. In summary, this demonstrates existence considerable liver insulinopenia complete blocking increases serum by despite levels. Thus, may play role determining bioavailability

参考文章(10)
Matthew M. Rechler, Insulin-like growth factor binding proteins. Vitamins and Hormones Series. ,vol. 47, pp. 1- 114 ,(1993) , 10.1016/S0083-6729(08)60444-6
D.R. Powell, A. Suwanichkul, M.L. Cubbage, L.A. DePaolis, M.B. Snuggs, P.D. Lee, Insulin inhibits transcription of the human gene for insulin-like growth factor-binding protein-1. Journal of Biological Chemistry. ,vol. 266, pp. 18868- 18876 ,(1991) , 10.1016/S0021-9258(18)55144-9
JENNIFER A. BATCH, ROBERT C. BAXTER, GEORGE WERTHER, Abnormal Regulation of Insulin-Like Growth Factor Binding Proteins in Adolescents with Insulin-Dependent Diabetes The Journal of Clinical Endocrinology and Metabolism. ,vol. 73, pp. 964- 968 ,(1991) , 10.1210/JCEM-73-5-964
Robert S. Bar, Mary Boes, David R. Clemmons, Walker H. Busby, Alexander Sandra, Brian L. Dake, Barbara A. Booth, Insulin differentially alters transcapillary movement of intravascular IGFBP-1, IGFBP-2 and endothelial cell IGF-binding proteins in the rat heart. Endocrinology. ,vol. 127, pp. 497- 499 ,(1990) , 10.1210/ENDO-127-1-497
ANNE-MARIA SUIKKARI, VEIKKO A. KOIVISTO, RIITTA KOISTINEN, MARKKU SEPPÄLÄ, HANNELE YKI-JÄRVINEN, Dose-response characteristics for suppression of low molecular weight plasma insulin-like growth factor-binding protein by insulin. The Journal of Clinical Endocrinology and Metabolism. ,vol. 68, pp. 135- 140 ,(1989) , 10.1210/JCEM-68-1-135
A. J. D'Ercole, A. D. Stiles, L. E. Underwood, Tissue concentrations of somatomedin C: further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action Proceedings of the National Academy of Sciences of the United States of America. ,vol. 81, pp. 935- 939 ,(1984) , 10.1073/PNAS.81.3.935
R A DeFronzo, J D Tobin, R Andres, Glucose clamp technique: a method for quantifying insulin secretion and resistance. American Journal of Physiology. ,vol. 237, pp. 214- 223 ,(1979) , 10.1152/AJPENDO.1979.237.3.E214
Jan L. Walker, Maria Ginalska-Malinowska, Tomasz E. Romer, Jolanta B. Pucilowska, Louis E. Underwood, Effects of the Infusion of Insulin-like Growth Factor I in a Child with Growth Hormone Insensitivity Syndrome (Laron Dwarfism) New England Journal of Medicine. ,vol. 324, pp. 1483- 1488 ,(1991) , 10.1056/NEJM199105233242107